CVS HEALTH CORPORATION Unrealized Gain (Loss) on Cash Flow Hedging Instruments
CVS HEALTH CORPORATION (CVS) had Unrealized Gain (Loss) on Cash Flow Hedging Instruments of $331.00 million as of 2018-03-09, per its 10-Q filed 2018-11-06.
Discontinued › Notes › Derivative Instruments and Hedging Activities
us-gaap:UnrealizedGainLossOnCashFlowHedgingInstruments · last filed 2018-11-06
- 2018-03-09: Unrealized Gain (Loss) on Cash Flow Hedging Instruments $331.00M.
| Period end | Unrealized Gain (Loss) on Cash Flow Hedging Instruments |
|---|---|
| 2018-03-09 | $331.00M 10-Q · filed 2018-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |